ScholarWorksIndianapolis
  • Communities & Collections
  • Browse ScholarWorks
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    or
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Subject

Browsing by Subject "France"

Now showing 1 - 6 of 6
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    An Origin Story for “Big Pharma” in the Reign of Louis XIV? An Early Modern History for the Present
    (Ruth Lilly Medical Library, 2024-04-05) Rivest, Justin
    Presentation slides for lecture delivered by Justin Rivest, PhD (Assistant Professor of History, Kenyon College) on April 5, 2024. This talk poses a fertile, if playfully anachronistic, historical question: In the final two decades of his seventy-two-year reign, did Louis XIV (r. 1643-1715) subsidize the world’s first “Big Pharma” companies into existence? From the 1680s onward the Sun King granted monopoly rights and government supply contracts, first to the court physician Jean-Baptiste Chomel, and then to the Dutch-born medical entrepreneur Adriaan Engelhard Helvetius (naturalized French as Adrien Helvétius). Both men developed proto-industrial operations that annually shipped tens of thousands of standardized medicine chests all over France and beyond. Building on relationships forged in supplying medicines to the French army, Rivest argues that they took advantage of supply problems in existing Catholic poor relief networks to provide their standardized medicines to the largest possible purchaser—the French absolutist state—and the largest possible consumer base—the peasants of rural France. Although grounded in the seventeenth and eighteenth centuries, this talk raises questions about the connections between charity and capitalism; the role of private entrepreneurs in fulfilling the state objectives; and about how the state shapes markets as a consumer, rather than just as a regulator, that continue to have resonance in the twenty-first century. Presentation recording available online: https://purl.dlib.indiana.edu/iudl/media/q47r66rn7r
  • Loading...
    Thumbnail Image
    Item
    Country Report 2018: France
    (2018) Dutheil, Philippe-Henri
    In France, there is no restriction concerning the purpose of a PO as long as the aim of the organization is not to share profits among members or to pursue an unlawful purpose. There are several kinds of POs, including associations and foundations, which are further subdivided into public utility foundations, sheltered foundations, corporate foundations, etc. and endowment funds. These organizations are subject to different regulatory regimes.
  • Loading...
    Thumbnail Image
    Item
    Infectious disease risks at the Rugby World Cup 2023 in France - Beware of Aedes and co!
    (Elsevier, 2023-09-09) Al-Tawfiq, Jaffar A.; Hedrich, Nadja; Lovey, Thibault; Gautret, Philippe; Schlagenhauf, Patricia; Medicine, School of Medicine
  • Loading...
    Thumbnail Image
    Item
    Mental Illness, Violence, and Anti-Blackness in France, c. 1900-1960
    (2022-12-07) Nelson, Elizabeth
  • Loading...
    Thumbnail Image
    Item
    Running in Circles: A Return to an Old Idea about Asylum Reform in Nineteenth-Century France
    (Proceedings of the Western Society for French History, 2014) Nelson, Elizabeth
  • Loading...
    Thumbnail Image
    Item
    The 2025 Global Philanthropy Environment Index France
    (Indiana University Lilly Family School of Philanthropy, 2025) Meynet, Wilfried; Pelatan, Alissa
About IU Indianapolis ScholarWorks
  • Accessibility
  • Privacy Notice
  • Copyright © 2025 The Trustees of Indiana University